USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
RELEASE DATE
29-Apr-2006
29-Apr-2006
REGION
North America
North America
Research Code: F205-01-00-00-00
SKU: HC01429-NA-MR_05888
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01429-NA-MR_05888
Description
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing rapidly and the forecast through 2011 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
Table of Contents
Emerging Therapeutics in the U.S. Colorectal Cancer Markets, U.S. Total Market for Colorectal Cancer
Executive Summary
- Executive Summary - Updated 4/2006
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Etiology
- Screening
- Diagnosis and Staging
- Treatment Overview
Patient Forecasts
- Incidence and Staging Forecasts
- Patient Forecasts by Line of Therapy
- Unmet Need Population Forecasts
Total Market Forecasts
- Total Market Forecasts - Updated 4/2006
- Market Share Analysis - Updated 4/2006
- Adjuvant Therapy Forecasts - Updated 4/2006
- First-line Therapy Forecasts - Updated 4/2006
- Second and Third-line Therapy Forecasts - Updated 4/2006
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Frost & Sullivan Awards
- Company of the Year Award
- Product of the Year Award
- Entrepreneurial Company of the Year Award
- Product Differentiation Innovation of the Year Award
- Best Bang for the Buck Award
Overview
Forecasts and Trends
Competitive Analysis
Overview
Angiogenesis Pathway
EGF Pathway
Cell Proliferation/Apoptosis Pathway
Immune Response Pathway
Revenue Forecasts
Competitive Analysis
Decision Support Databases
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing rapidly and the forecast through 2011 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F205-01-00-00-00 |
| Is Prebook | No |